Search for dissertations about: "VLDL secretion"
Showing result 1 - 5 of 27 swedish dissertations containing the words VLDL secretion.
-
1. Assembly and Secretion of Atherogenic Lipoproteins
Abstract : The classical dyslipidemia seen in patients with type 2 diabetes is characterized by elevated serum triglycerides (TG), low levels of high-density lipoprotein cholesterol and the appearance of small, dense low-density lipoproteins (LDL). It is now recognized that the different components of diabetic dyslipidemia are not isolated abnormalities but are closely linked to each other metabolically, and are initiated by the hepatic overproduction of large triglyceride-rich very low-density lipoproteins (VLDL1). READ MORE
-
2. The assembly and secretion of ApoB containing lipoproteins
Abstract : Increased levels of cholesterol and triglycerides in the blood are important risk factors for the development of premature atherosclerosis and its complications such as coronary-heart diseases, stroke and peripheral vascular diseases. These diseases are the major causes of death in Europe, USA and part of Asia. READ MORE
-
3. Effects of ARF1 and phospholipase D on the assembly and secretion of apoB-100 containing lipoproteins
Abstract : Hydrophobic insoluble lipids such as triglycerides and cholesterol ester are transported in spherical, water-soluble molecular complexes called lipoproteins. Lipoproteins are secreted mainly from the liver and intestine into the plasma for distribution to peripheral tissues. READ MORE
-
4. Growth hormone and PPARa in the regulation of lipoprotein metabolism
Abstract : In humans, apolipoprotein B (apoB)-100 is produced in the liver and apoB-48 is formed in the intestine. In the rat, however, the two forms of apoB are produced in the liver, leading to the formation of VLDL consisting of either apoB-48 or apoB-100. READ MORE
-
5. GH, IGF-1 and insulin in the regulation of lipid and lipoprotein metabolism
Abstract : It is well known that growth hormone (GH) has profound effects on lipid and lipoprotein metabolism. Insulin-like growth factor-I (IGF-I) is believed to mediate some of the effects of GH via endocrine and paracrine mechanisms. Moreover, both GH and IGF-I are known to influence insulin secretion. READ MORE